VisionGate Presents at the World Conference on Lung Cancer for 2016 in Vienna: The Non-Invasive LuCED® test for Detection of Early Stage Lung Cancer
VisionGate Presents Blinded Trial Data at WCLC 2016 PHOENIX, Ariz. (December 15, 2016) – More than 1.5 million people in the United States will have suspicious nodules detected incidentally in their lungs this [...]